NM_021098.3:c.1664C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.1664C>T​(p.Ala555Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0153 in 1,546,262 control chromosomes in the GnomAD database, including 189 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A555T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 9 hom., cov: 34)
Exomes 𝑓: 0.015 ( 180 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.12

Publications

7 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021456778).
BP6
Variant 16-1202114-C-T is Benign according to our data. Variant chr16-1202114-C-T is described in ClinVar as [Benign]. Clinvar id is 96001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0145 (2208/152338) while in subpopulation NFE AF = 0.0166 (1132/68016). AF 95% confidence interval is 0.0158. There are 9 homozygotes in GnomAd4. There are 1033 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 2208 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1625C>T p.Ala542Val missense_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1625C>T p.Ala542Val missense_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1664C>T p.Ala555Val missense_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000711442.1 linkn.*1111C>T non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1664C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*1111C>T 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+279C>T intron_variant Intron 9 of 34 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.0145
AC:
2206
AN:
152220
Hom.:
9
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0156
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0165
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.0166
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.0111
AC:
1547
AN:
139104
AF XY:
0.0108
show subpopulations
Gnomad AFR exome
AF:
0.0155
Gnomad AMR exome
AF:
0.00849
Gnomad ASJ exome
AF:
0.00959
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0178
Gnomad NFE exome
AF:
0.0175
Gnomad OTH exome
AF:
0.0102
GnomAD4 exome
AF:
0.0154
AC:
21496
AN:
1393924
Hom.:
180
Cov.:
36
AF XY:
0.0149
AC XY:
10270
AN XY:
687418
show subpopulations
African (AFR)
AF:
0.0160
AC:
505
AN:
31532
American (AMR)
AF:
0.00842
AC:
300
AN:
35618
Ashkenazi Jewish (ASJ)
AF:
0.00928
AC:
233
AN:
25096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35680
South Asian (SAS)
AF:
0.000543
AC:
43
AN:
79154
European-Finnish (FIN)
AF:
0.0177
AC:
807
AN:
45562
Middle Eastern (MID)
AF:
0.00211
AC:
12
AN:
5690
European-Non Finnish (NFE)
AF:
0.0175
AC:
18857
AN:
1077716
Other (OTH)
AF:
0.0128
AC:
739
AN:
57876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1473
2946
4420
5893
7366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0145
AC:
2208
AN:
152338
Hom.:
9
Cov.:
34
AF XY:
0.0139
AC XY:
1033
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0156
AC:
648
AN:
41582
American (AMR)
AF:
0.0108
AC:
166
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.0165
AC:
175
AN:
10630
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.0166
AC:
1132
AN:
68016
Other (OTH)
AF:
0.0170
AC:
36
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
126
252
377
503
629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0147
Hom.:
9
Bravo
AF:
0.0148
TwinsUK
AF:
0.0148
AC:
55
ALSPAC
AF:
0.0161
AC:
62
ESP6500AA
AF:
0.00958
AC:
24
ESP6500EA
AF:
0.0162
AC:
96
ExAC
AF:
0.00573
AC:
429
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 10, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Jul 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Apr 16, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.21
DANN
Benign
0.90
DEOGEN2
Benign
0.10
T;.;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.19
T;T;T;.
MetaRNN
Benign
0.0021
T;T;T;T
MetaSVM
Uncertain
-0.13
T
MutationAssessor
Benign
0.42
N;.;N;N
PhyloP100
-2.1
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.18
N;.;N;N
REVEL
Benign
0.16
Sift
Benign
0.48
T;.;T;T
Sift4G
Benign
0.55
T;.;T;T
Polyphen
0.0020
B;.;B;B
Vest4
0.077
ClinPred
0.00092
T
GERP RS
-2.5
Varity_R
0.042
gMVP
0.29
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9924241; hg19: chr16-1252114; API